Carson Wealth (CWM LLC)
RARE icon

Carson Wealth (CWM LLC)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$934K Buy
44,571
+31,446
+240% +$708K ﹤0.01% 1577
2025
Q4 		$302K Buy
13,125
+9,028
+220% +$297K ﹤0.01% 2252
2025
Q3 		$123K Sell
4,097
-47
-1% -$1.41K ﹤0.01% 2816
2025
Q2 		$151K Buy
4,144
+3,818
+1,171% +$138K ﹤0.01% 2407
2025
Q1 		$12K Sell
326
-872
-73% -$36.3K ﹤0.01% 4019
2024
Q4 		$50K Sell
1,198
-20,134
-94% -$999K ﹤0.01% 2803
2024
Q3 		$1.19M Buy
21,332
+21,111
+9,552% +$1.08M 0.01% 929
2024
Q2 		$9K Sell
221
-893
-80% -$38.1K ﹤0.01% 3624
2024
Q1 		$52K Buy
1,114
+789
+243% +$37.2K ﹤0.01% 2277
2023
Q4 		$16K Buy
325
+104
+47% +$4.03K ﹤0.01% 2919
2023
Q3 		$8K Buy
221
+191
+637% +$7.57K ﹤0.01% 3264
2023
Q2 		$1K Buy
30
+3
+11% +$139 ﹤0.01% 4042
2023
Q1 		$1K Buy
27
+5
+23% +$215 ﹤0.01% 3903
2022
Q4 		$1K Sell
22
-24
-52% -$944 ﹤0.01% 3820
2022
Q3 		$2K Sell
46
-128
-74% -$6.58K ﹤0.01% 3523
2022
Q2 		$10K Buy
174
+149
+596% +$9.17K ﹤0.01% 2599
2022
Q1 		$2K Buy
+25
New +$1.74K ﹤0.01% 3214
2018
Q4 		– Sell
-3
Closed – – 2218
2018
Q3 		$0 Hold
3
– – ﹤0.01% 1963
2018
Q2 		$0 Hold
3
– – ﹤0.01% 1760
2018
Q1 		$0 Hold
3
– – ﹤0.01% 1519
2017
Q4 		$0 Hold
3
– – ﹤0.01% 1556
2017
Q3 		$0 Hold
3
– – ﹤0.01% 1547
2017
Q2 		$0 Hold
3
– – ﹤0.01% 1285
2017
Q1 		$0 Buy
+3
New +$229 ﹤0.01% 1288

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RARE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Ultragenyx Pharmaceutical (RARE) stake by 240% in Q1 2026, buying an estimated $708K and bringing the position to 44,571 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Carson Wealth (CWM LLC) first reported a position in RARE in Q1 2017 and has held it in 24 quarters since. The position peaked at $1.19M in Q3 2024. 297 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 44,571 shares of Ultragenyx Pharmaceutical worth $934K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 31,446 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $708K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1577 holding.
  • Carson Wealth (CWM LLC) first reported a position in Ultragenyx Pharmaceutical in Q1 2017 and has held it in 24 quarters since.
  • Carson Wealth (CWM LLC)'s Ultragenyx Pharmaceutical position peaked at $1.19M in Q3 2024.
  • 297 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.